
Accurate DNA quantification is critical for determining the appropriate analytical approach in forensic investigations. Conventional workflows often require separate quantitative PCR (qPCR) assays for nuclear and mitochondrial DNA, increasing sample consumption, processing time and reagent requirements.
In this webinar, Dr. Priyankaa Bhatia from the FBI Laboratory Division, Research and Support Unit will discuss the development and evaluation of an eight-dye digital PCR assay using the QIAGEN QIAcuity dPCR Platform. The assay simultaneously measures nuclear, male and mitochondrial DNA targets alongside an internal positive control. Learn how the assay was optimized and evaluated for sensitivity, specificity, inhibitor tolerance and performance with mock casework samples. The findings demonstrate the potential of multiplex dPCR to improve forensic sample triage and support downstream analysis decisions while preserving valuable evidence.
This work is the result of a forthcoming Collaborative Research and Development Agreement (CRADA) between the Federal Bureau of Investigation Federal Laboratory and QIAGEN Sciences Inc.
Names of commercial manufacturers are provided for identification purposes only, and inclusion does not imply endorsement of the manufacturer or its products or services by the FBI. Any reproduction or other use of these presentation materials without the express written consent of the FBI is prohibited. The views expressed are those of the author(s) and do not necessarily reflect the official policy or position of the U.S. Government.